WELL Health Technologies Corp (WELL)

WELL Health Strengthens Clinical and Public Sector Leadership with Appointment of Dr. Andrew Bond as Chief Health Officer and Head of Public SectorJune 5, 2026 6:30 AM
NewsfileWELL appoints accomplished physician executive and health system leader Dr. Andrew Bond as Chief Health Officer and Head of Public Sector to lead clinical governance and performance, government relations, and growth in public sector solutions.Dr. Bond brings more than 20 years of clinical and healthcare leadership experience spanning primary care, emergency medicine, public policy, and digital health, across organizations including GreenShield and academic institutions across Canada and the United States.Dr. Bond's appointment reflects WELL's increasing focus on partnering with governments and public health systems while advancing clinical governance across its national care delivery and technology platform in partnership with the WELL Group of companies including WELL Canadian Clinics, WELLSTAR and HEALWELL AI.Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the appointment of Dr. Andrew Bond as Chief Health Officer ("CHO") and Head of Public Sector, effective immediately. Dr. Bond's appointment reflects WELL's increasing focus on partnering with governments and public health systems while advancing clinical governance across its national care delivery and technology platform.Dr. Bond brings more than two decades of clinical practice and healthcare leadership experience spanning primary care, hospitalist and emergency medicine, public policy, government relations, and digital health. Most recently, he served as Senior Vice President and Chief Medical Officer at GreenShield, where he held broad clinical and administrative leadership responsibilities across one of Canada's leading health and benefits organizations.Throughout his career, Dr. Bond has held numerous clinical, administrative, and academic leadership roles across Ontario, Nunavut, and British Columbia. He is a Board Member of AMS Healthcare, a charitable endowment supporting AI and technology adoption in the healthcare sector and is a Fellow of the College of Family Physicians of Canada. Dr. Bond continues to practice as a primary care physician and serves as a faculty member in the Department of Family and Community Medicine at the Temerty Faculty of Medicine, University of Toronto.Dr. Bond holds a Master of Health Administration (MHA) from the Johnson Shoyama Graduate School of Public Policy at the Universities of Saskatchewan and Regina, a Master of Business Administration (MBA) from the Massachusetts Institute of Technology, and a Certified Health Executive (CHE) designation from the Canadian College of Health Leaders.Hamed Shahbazi, Chairman and CEO of WELL commented, "We are pleased to welcome Dr. Bond to WELL's executive leadership team. Andrew is an exceptional physician leader with a rare combination of frontline clinical experience, academic depth, and executive leadership across some of Canada's most complex health organizations. His expertise in clinical governance, public sector partnerships, and the responsible deployment of health technology aligns perfectly with WELL's mission and our ambitions as a national healthcare delivery and technology platform. Dr. Bond's appointment comes at an important time as governments and healthcare organizations increasingly seek trusted partners capable of delivering scalable, secure and AI enabled healthcare solutions. We look forward to the significant impact he will have on both our organization and the broader Canadian health system."Dr. Bond commented, "I am thrilled to be joining WELL at such an important time in its transformative growth. Canadians deserve sovereign health solutions that deliver excellent, accessible, integrated and efficient care at scale, deploying the most advanced technologies responsibly and securely. WELL is without peer in realizing this ambition across preventive health, diagnostics and medical care through its national clinic network and system enabling technologies. I look forward to working with WELL's skilled and purpose-driven staff to continue to accelerate their impact for the health of Canadians and WELL's role as a partner in building and sustaining high-performing health systems."As CHO and Head of Public Sector, Dr. Bond will report directly to Hamed Shahbazi, Chairman and CEO, and will work closely with WELL's executive leadership team to strengthen clinical governance and performance, advance government and public sector partnerships, and support the responsible deployment of technology across WELL's portfolio. In connection with this appointment, Dr. Bond assumes senior clinical leadership of operations across the WELL Group of companies, with the Company's network of Chief Medical Officers reporting to him. This transition allows Dr. Michael Frankel, who previously served as Group Chief Medical Officer, to focus entirely on his role as President of Canadian Clinics. In this role, Dr. Bond will lead WELL's engagement with federal, provincial and territorial governments, health authorities and healthcare stakeholders, helping expand opportunities across digital health infrastructure, healthcare delivery, and AI enabled clinical solutions in partnership with WELLSTAR and HEALWELL AI. Dr. Bond's appointment further strengthens WELL's leadership bench as the Company continues to expand its role as a technology enabled healthcare partner to providers, patients and public health systems across Canada.WELL HEALTH TECHNOLOGIES CORP.Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and DirectorAbout WELL Health Technologies Corp.WELL Health Technologies Corp. (TSX: WELL) is Canada's largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates approximately 270 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services. WELL provides cybersecurity services through its CYBERWELL subsidiary. WELL is publicly-traded on the TSX under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF". To learn more, please visit: www.well.company.Neither the TSX nor its Regulation Services Provider (as that term is defined in policies of the TSX) accepts responsibility for the adequacy or accuracy of this release. For further information:
Pardeep Sangha
Vice President, Investor Relations

WELL Health Improves Guidance Based on WELL Canada Achieving $100 Million in Annualized Adjusted EBITDA Run-Rate Ahead of ScheduleJune 2, 2026 6:30 AM
NewsfileWELL has reached its goal of $100 million in annualized Adjusted EBITDA(1) run-rate for WELL Canada, three calendar quarters ahead of schedule, driven by strong organic growth across WELL Clinics and WELLSTAR together with two accretive acquisitions.WELL had previously guided a $100 million annualized Adjusted EBITDA(1) run-rate by Q1-2027 on approximately $800 million of revenue. The Company has delivered it on approximately $700 million of revenue, implying an Adjusted EBITDA Margin(1) of approximately 14% - roughly 180 basis points ahead of prior guidance.On June 1, 2026, WELL closed two complementary, immediately accretive acquisitions in Ontario and Québec, focused on diagnostic imaging and procedural care: 100% of the OID Group and approximately 65% controlling interest in UnionMD. The Company paid approximately $115 million at closing for both acquisitions, expanding its Canadian Clinics network to approximately 270 clinics nationally. The total purchase price for these two transactions could amount to $160 million, inclusive of future earn-outs and vendor take-back financing.The two acquisitions generated combined Adjusted EBITDA(1) of approximately $22 million in 2025, reflecting Adjusted EBITDA Margins(1) of well over 25%, and bringing WELL Canadian Clinics to well over $80 million in annualized Adjusted EBITDA(1) run-rate.On the strength of this performance and the contribution of the completed acquisitions, WELL now expects to exceed the top end of its previously announced 2026 Adjusted EBITDA(1) guidance range of $175 million to $185 million. The Company intends to provide a formal update to its 2026 outlook in connection with announcing its second quarter financial results.Vancouver, British Columbia--(Newsfile Corp. - June 2, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, today announced that it has achieved its goal of $100 million in annualized Adjusted EBITDA(1) run-rate for its WELL Canada segment, three calendar quarters ahead of the timeline it had previously guided to, and at materially better margins. This milestone reflects the combined strength of WELL's organic growth and its disciplined acquisition strategy across the Canadian business. In conjunction with reaching this milestone, WELL also announced the closing of two complementary, immediately accretive clinical platform acquisitions: a network of outpatient diagnostic imaging clinics in Ontario operating primarily under the Ontario Imaging Diagnostics brand ("OID Group"), and a majority controlling interest in JDMD Inc. ("UnionMD"), one of Québec's largest multi-disciplinary healthcare platforms.These two acquisitions generated combined Adjusted EBITDA(1) of approximately $22 million in 2025 reflecting Adjusted EBITDA Margins(1) of well over 25%. With these acquisitions, WELL's Canadian Clinics network has expanded to approximately 270 clinics, with approximately 2,350 billable healthcare providers. Together, they are expected to bring WELL Canadian Clinics to well over $80 million in annualized Adjusted EBITDA(1) run-rate and WELL Canada, which includes Canadian Clinics, WELLSTAR and CYBERWELL, to over $100 million in annualized Adjusted EBITDA(1) run-rate. Both acquisitions were fully funded through the Company's cash on hand and existing credit facilities.Reaching and exceeding $100 million in annualized Adjusted EBITDA(1) run-rate for WELL Canada represents a key milestone for the Company. Through a combination of strong organic growth and disciplined acquisitions, WELL has firmly reached this goal three calendar quarters earlier than previously guided. The Company had previously guided that it expected to reach $100 million in annualized Adjusted EBITDA(1) run-rate for WELL Canada by the first quarter of 2027 on associated revenue of approximately $800 million. WELL has delivered this run-rate on associated revenue of approximately $700 million, implying an Adjusted EBITDA Margin(1) of approximately 14% - approximately 180 basis points ahead of the margin implied by the Company's prior guidance.On the strength of this performance and the contribution of these completed acquisitions, WELL expects to exceed the top end of its previously announced 2026 Adjusted EBITDA(1) guidance range of $175 million to $185 million. The Company intends to provide a formal update to its 2026 outlook in connection with announcing its second quarter financial results.Hamed Shahbazi, Chairman and CEO of WELL, commented, "Reaching $100 million in annualized Adjusted EBITDA run-rate for WELL Canada three calendar quarters ahead of schedule, and at materially better margins than we had guided to, is a milestone we are very proud of. What makes it especially meaningful is how we got here. This is the result of total performance across our Canadian business - strong organic growth at both WELL Clinics and WELLSTAR, complemented by disciplined, accretive acquisitions. Our model is working, and we are reaching our goals faster and more profitably than planned. We now turn much of our attention to integration and operational execution across the platform. We look forward to sharing more with our second quarter results."In Ontario, WELL has acquired the OID Group, a network of outpatient diagnostic imaging clinics operating primarily under the Ontario Imaging Diagnostics brand. In Québec, WELL has acquired a majority controlling interest in UnionMD, one of the province's largest and multi-disciplinary healthcare platforms, a procedure-first business. Both acquisitions achieved Adjusted EBITDA Margins(1) of well over 25% in 2025. The aggregate purchase price paid at closing of $115 million for these two transactions was fully funded through proceeds from the newly expanded and extended senior secured credit facility arranged with a syndicate of lenders led by Royal Bank of Canada, JPMorgan Chase Bank, N.A., and Toronto-Dominion Bank in January 2026. The total purchase price for these two transactions could amount up to $160 million, inclusive of future earn-outs and vendor take-back financing.Dr. Michael Frankel, President of Canadian Clinics, commented, "Both of these acquisitions bring strong, well-established clinical teams into the WELL network and reflect the depth of talent that exists across the Canadian healthcare landscape. We look forward to bringing these clinics into the WELL ecosystem, leveraging our shared services infrastructure and technology platforms to enhance operational efficiency and the experience for both patients and providers."Beyond their standalone contribution, both acquisitions are expected to benefit from WELL's shared services infrastructure, technology platforms, and proven clinic operating model. WELL has identified a range of opportunities to enhance performance across the acquired platforms, including expanded capacity and other synergies across WELL's national network. The Company believes these initiatives, combined with the platforms' already strong margin profiles, will further support WELL Canada's profitability over time. WELL intends to provide additional detail on its integration and value-creation plans in connection with announcing its second quarter financial results. Footnotes:Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP financial measures. Please refer to WELL's most recent Management's Discussion and Analysis (MD&A), available under the Company's profile on SEDAR+ at www.sedarplus.ca, for further details including definitions and reconciliations to the nearest IFRS measure. WELL HEALTH TECHNOLOGIES CORP.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director About WELL Health Technologies Corp.WELL Health Technologies Corp. (TSX: WELL) is Canada's largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates approximately 270 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services. WELL provides cybersecurity services through its CYBERWELL subsidiary. WELL is publicly-traded on the TSX under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF". To learn more, please visit: www.well.company.Forward-Looking StatementsThis news release may contain "Forward-Looking Information" within the meaning of applicable Canadian securities laws, including, without limitation: information regarding the Company's goals, strategies and growth plans; expectations regarding continued revenue and EBITDA growth; the expected benefits and synergies of completed acquisitions; 2026 guidance affirmation/improvement, long-term strategic objectives, liquidity expectations, WELL's acquisition pipeline, WELL's growth initiatives, revenue and other financial contributions from completed acquisitions, as well as information in the "Outlook" section herein. Forward-Looking Information are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-Looking Information generally can be identified by the use of forward-looking words such as "may", "should", "will", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Forward-Looking Information involve known and unknown risks, uncertainties and other factors that may cause future results, performance, or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by the Forward-Looking Information and the Forward-Looking Information are not guarantees of future performance. WELL's comments expressed or implied by such Forward-Looking Information are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL 's control, and undue reliance should not be placed on such information. Forward-Looking Information are qualified in their entirety by inherent risks and uncertainties, including without limitation: adverse market conditions and the ability to complete acquisitions; risks inherent in the primary healthcare sector in general; continued patient and consumer demand for WELL's products and services; regulatory and legislative changes; that future results may vary from historical results; the inability to obtain any requisite future financing on suitable terms; any inability to realize the expected benefits and synergies from acquisitions; that market competition may affect the business, results and/or financial condition of WELL and other risk factors identified in documents filed by WELL under its profile at www.sedarplus.ca, including its most recent Annual Information Form. Except as required by securities laws, WELL does not assume any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise.This news release contains financial outlook information (collectively, "FOI") about estimated annual run-rate revenue for WELL Canada, Adjusted EBITDA, and Adjusted EBITDA Margins all of which are subject to the same assumptions, risk factors, limitations, and qualifications as set out in the above paragraph. The actual financial results of WELL may vary from the amounts set out herein and such variation may be material. WELL and its management believe that the FOI has been prepared on a reasonable basis, reflecting management's best estimates and judgments. However, because this information is subjective and subject to numerous risks, it should not be relied on as necessarily indicative of future results. Except as required by applicable securities laws, WELL undertakes no obligation to update such FOI. FOI contained in this news release was made as of the date hereof and was provided for the purpose of providing further information about WELL's anticipated future business operations on an annual basis. Readers are cautioned that the FOI contained in this news release should not be used for purposes other than for which it is disclosed herein.Neither the TSX nor its Regulation Services Provider (as that term is defined in policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.For further information:Pardeep Sangha
Vice President, Investor Relations

WELL Health Announces Appointment of Healthcare Executive Derek Clark as Chief Operating OfficerMay 27, 2026 7:00 AM
NewsfileWELL appoints seasoned healthcare and digital health executive Derek Clark as Chief Operating Officer to support the Company's next phase of operational execution and scale. Mr. Clark brings more than 20 years of healthcare leadership experience spanning digital health, diagnostic imaging, clinical services, and healthcare technology, across companies including Calian and GE Healthcare.Vancouver, British Columbia--(Newsfile Corp. - May 27, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the appointment of Derek Clark as Chief Operating Officer ("COO"), effective immediately.Mr. Clark brings more than two decades of leadership experience across healthcare services, digital health, diagnostic imaging, healthcare technology, and complex multi-entity operations. Most recently, he served as President of Essential Industries at Calian Group Ltd., where he led a diversified portfolio spanning clinical services, digital health, pharma, IT, cyber, and energy, achieving strong financial and operational results. Prior to Calian, Mr. Clark spent 18 years at GE and GE Healthcare in progressively senior roles, most notably as Chief Commercial Officer for GE Canada, where he oversaw a $2.5B portfolio and drove growth across healthcare, energy, and industrial businesses. Mr. Clark holds a Bachelor of Engineering and Management degree from McMaster University and an MBA from the Ivey Business School at Western University. Hamed Shahbazi, Chairman and CEO of WELL commented, "We are extremely pleased to welcome Derek to WELL's executive leadership team. Derek is a highly accomplished healthcare executive with extensive experience leading complex healthcare and digital health organizations. His deep expertise across healthcare operations, diagnostic imaging, M&A integration, and enterprise operating systems will be invaluable as WELL continues to scale its platform and execute on its growth strategy. Derek's leadership experience brings a combination of entrepreneurial thinking and operational rigor that aligns exceptionally with WELL's culture and long-term ambitions."Mr. Clark commented, "I am excited to join WELL at such an important stage in the Company's evolution. WELL has built one of the most impressive healthcare and digital health platforms in Canada and continues to demonstrate strong execution and innovation across the healthcare ecosystem. I look forward to working with the talented team at WELL to further strengthen operational capabilities and continue supporting healthcare practitioners with leading technology-enabled solutions."As COO, Mr. Clark will report directly to Hamed Shahbazi, Chairman and CEO, and will work closely with WELL's executive leadership team to further enhance operational execution, scalability, integration, and enterprise performance management across the Company's portfolio of healthcare and digital health assets. His mandate will include driving operating discipline, supporting strategic growth initiatives, optimizing cross-functional collaboration, and helping scale WELL's platform.WELL HEALTH TECHNOLOGIES CORP.Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and DirectorAbout WELL Health Technologies Corp.WELL Health Technologies Corp. (TSX: WELL) is Canada's largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services. WELL provides cybersecurity services through its CYBERWELL subsidiary. WELL is publicly traded on the TSX under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF". To learn more, please visit: www.well.company.Neither the TSX nor its Regulation Services Provider (as that term is defined in policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.For further information:Pardeep Sangha
Vice President, Investor Relations

WELL Health Announces Approval of Normal Course Issuer BidMay 19, 2026 7:00 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Notice of Intention to Make a Normal Course Issuer Bid ("NCIB") it filed with the Toronto Stock Exchange ("TSX") has been approved by the TSX and has subsequently entered into an automatic share purchase plan ("ASPP") with a broker in order to facilitate repurchases of the Company's common shares (the "Shares"). The NCIB is a renewal of its NCIB that is set to expire on May 19, 2026 (the "2025 NCIB").WELL believes that purchases of its Shares pursuant to the NCIB may contribute to the facilitation of an orderly market and be in the best interests of the Company and its shareholders. In the event that WELL believes that its Shares begin trading in a price range that does not adequately reflect their underlying value based on WELL's business prospects and financial position, WELL may purchase Shares pursuant to the NCIB. Depending upon future price movements and other factors, WELL believes that its outstanding Shares may represent an attractive investment and a desirable use of a portion of its corporate funds. As of May 7, 2026, the Company had 255,408,705 Shares issued and outstanding. Under the NCIB, the Company may acquire up to an aggregate of 12,770,172 Shares over the next 12-month period, representing approximately 5.0% of the issued and outstanding Shares of the Company. In accordance with TSX rules, daily purchases made by the Company on the TSX will not exceed 383,933 Shares, subject to certain prescribed exemptions, being 25% of the average daily trading volume over the preceding six calendar months of 1,535,732 Shares. The NCIB will be effective from May 21, 2026 to May 20, 2027.?Purchases subject to this NCIB will be made on the open market through the facilities of the TSX and any Canadian alternative trading systems in Canada by a broker on behalf of the Company in accordance with applicable regulatory requirements. All Shares purchased under the NCIB will be returned to treasury for cancellation.? As of the date of the Company's application to the TSX for the NCIB, the Company purchased 654,100 Shares through the facilities of the TSX and/or alternative Canadian trading systems with a weighted average price of $4.31 per Share under the 2025 NCIB. Although the Company was eligible to purchase up to 6,329,136 Shares, the Company allocated funds to alternative capital allocation opportunities to provide greater returns to shareholders. During the effective period of WELL's ASPP, WELL's broker may purchase Shares at times when WELL would not be active in the market due to insider trading rules and its own internal trading blackout periods. Purchases will be made by WELL's broker based upon parameters set by WELL when it is not in possession of any undisclosed material information about itself and its securities, and in accordance with the terms of the ASPP. Outside of the effective period of the ASPP, Shares may continue to be purchased in accordance with WELL's discretion, subject to applicable law. The ASPP has been entered into in accordance with the requirements of applicable Canadian securities laws.To the knowledge of the Company, no director, senior officer, or other insider of the Company or any of their associates currently intends to sell any Shares under this bid. However, sales by such persons through the facilities of the TSX or any other available market or alternative trading system in Canada may occur if the personal circumstances of any such person change or if any such person makes a decision unrelated to these normal course purchases. The benefits to any such person whose Shares are purchased would be the same as the benefits available to all other holders whose Shares are purchased. WELL HEALTH TECHNOLOGIES CORP.Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director About WELL Health Technologies Corp.WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) is Canada's largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 4 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services. WELL provides cybersecurity services through its CYBERWELL subsidiary. WELL is publicly traded on the TSX under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF". To learn more, please visit: www.well.company.For further information:Pardeep Sangha
Vice President, Investor Relations

WELL Health to Announce First Quarter 2026 Financial Results on May 7, 2026April 28, 2026 7:00 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - April 28, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Company will release its Fiscal First Quarter 2026 financial results for the period ended March 31, 2026, after market close on Thursday, May 7, 2026. The Company will hold a conference call and simultaneous webcast to discuss its results on the same day, at 5:00 PM ET (2:00 PM PT). The call will be hosted by Hamed Shahbazi, Chairman and Chief Executive Officer, and Eva Fong, Chief Financial Officer. Please dial in 10 minutes prior to the start of the call.Conference Call Participant DetailsDate:Thursday, May 7, 2026Time: 5:00 PM ET / 2:00 PM PTInternational Toll:1-289-514-5100North American Toll Free:1-800-717-1738To attend the webcast, register here or visit well.company/events for details. WELL HEALTH TECHNOLOGIES CORP.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director About WELL Health Technologies Corp.WELL Health Technologies Corp. (TSX: WELL) is Canada's largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 4 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services. WELL provides cybersecurity services through its CYBERWELL subsidiary. WELL is publicly traded on the TSX under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF." To learn more, please visit: www.well.company. For further information:Pardeep Sangha
Vice President Investor Relations

WELL Health Reports Record Canadian Patient Visits and Primary Care Margin Expansion in Q1-2026April 21, 2026 7:00 AM
NewsfileWELL Canada delivered a record ~1.27 million patient visits(1) in Q1-2026, representing 33% year-over-year growth and 13% organic growth, reflecting broad-based strength across its national network.Primary Care Adjusted EBITDA(2) margins expanded to approximately 8% in Q1-2026 on a preliminary basis, up approximately 200 basis points from 6% in Q1-2025, driven by WELL's clinic transformation program and recent accretive acquisitions. Specialty Care margins continued to comfortably exceed 20%.Affiliate Clinic network expanded to 74 licensee locations, reflecting the continued build-out of WELL's ten-year strategic alliance with a large retailer that WELL partnered with in December 2024. The model is highly recurring, high-margin, and capital-light, giving physicians access to high-traffic retail locations nationally.CardiologyNow virtual visits grew 65% year-to-date, supported by expanded specialist capacity and strong referral demand, reinforcing its role as a key access point into WELL's national diagnostics network.Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, today reported record quarterly patient visits across its Canadian Clinics network and highlighted continued organic growth, margin expansion in its Primary Care segment, the continued scaling of its Affiliate Clinic network, and strong momentum in its CardiologyNow virtual specialty-care platform.Hamed Shahbazi, Chairman and CEO of WELL, commented, "Our Canadian Clinics network delivered another record quarter, with approximately 1.27 million patient visits and 13% organic growth reflecting the underlying health and compounding value of our platform. Beyond the headline number, we are seeing real operating leverage emerge: margins in Primary Care are expanding as our clinic transformation program takes hold, our Affiliate Clinic network continues to scale in a capital-light manner, and CardiologyNow is rapidly becoming a leading virtual specialty-care platform in Canada. Together, these are the some of the proof points that continue to give us confidence in the durability of WELL's growth."Steep Increase in Providers Drives Record Patient Visits and Continued Organic GrowthWELL delivered a record 1.27 million Canadian patient visits?¹? in Q1-2026, representing a 33% increase year-over-year and 13% organic growth. Organic growth was comprised of 8% same-clinic growth and 5% from clinic absorptions(3), reflecting strong underlying demand for primary and specialty care, improved clinic utilization, and operational efficiencies enabled by WELL's tech-enabled platforms.WELL's Canadian clinic network expanded to 253 clinics at quarter end, an addition of 33 clinics or 15% growth compared to Q1-2025, with the majority of additions completed in Ontario and Alberta, two of Canada's highest-demand healthcare markets. The Company's Canadian network now includes over 3,100 providers, up 17% year-over-year, with physicians representing the fastest-growing segment of the provider base at 22% year-over-year growth.WELL continues to maintain a strong pipeline of acquisition and clinic absorption opportunities, reinforcing its position as Canada's leading consolidator of outpatient healthcare assets.WELL Canada Patient Visits, Clinic Count and Healthcare Providers
Q1-2026Q1-2025Y/Y GrowthQuarterly Canada Patient Visits1,270,005957,03233%Canadian Clinic Counts (at quarter end)25322015%Canadian Providers (at quarter end)3,1582,71017% WELL Canada Patient Visits Q1-2026 Growth BreakdownPatient Visit GrowthY/Y GrowthSame Clinic8%Absorption(3)5%Total Organic13%Inorganic Growth20%Total Patient Visit Growth33% Primary Care Margin ExpansionOn a preliminary basis, WELL's Primary Care segment is expected to deliver Adjusted EBITDA margins(2) of approximately 8% in Q1-2026, up approximately 200 basis points from 6% in Q1-2025. The improvement reflects the combined impact of accretive acquisitions and ongoing execution of WELL's clinic transformation program. Specialty Care margins continued to comfortably exceed 20% in the quarter, underscoring the attractive economics of WELL's higher-acuity service lines.WELL's clinic transformation program is a disciplined, data-driven initiative designed to enhance efficiency, patient throughput, and profitability across clinics that are often operating at or near break-even at the time of acquisition. The program covers clinic integration, digital readiness, implementation of core technologies, and ongoing performance optimization, and is delivering measurable improvements in operating performance across WELL's network.Affiliate Clinic Network Expands to 74 Locations with National Retail Partner WELL's Affiliate Clinic network has grown to 74 licensee locations across Canada, up from 59 locations at the time WELL entered its ten-year strategic alliance with a large retailer in December 2024. The network now spans six provinces: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Québec, with expansion achieved through a combination of greenfield clinic development and the reopening of previously closed locations formerly operated by the prior provider.Affiliate clinics are physician or third-party-owned and operated practices located within WELL-managed clinic spaces inside high-traffic retail locations. These practices retain full control over their clinical and staffing operations while benefiting from WELL-controlled real estate, national scale, and optional access to WELL's digital and operational support tools. The model is highly recurring, high-margin, and capital-light, and also represents an attractive cross-sell channel for WELLSTAR's digital health solutions, including EMR, billing and revenue cycle management, patient engagement, and AI-enabled clinical and administrative tools.Strong Momentum in CardiologyNow Virtual VisitsCardiologyNow is WELL Health Diagnostics' rapid-access virtual cardiology consultation service, powered by a WELLSTAR digital platform, which connects patients and primary care providers with specialty care and diagnostic imaging. The platform delivered a 65% year-to-date increase in consultation billings compared to the same period last year.Growth has been driven by the addition of 35 new cardiologists and internal medicine physicians, expanded referral intake from WELL's primary care network, and increased service demand. WELL's recently announced partnership with AliveCor is expected to further contribute to this momentum in Q2-2026 and beyond, expanding access to remote cardiac monitoring and enabling timely cardiologist oversight through AI-powered ECG technology.As Canada's largest cardiology and medical diagnostic network, WELL's platform serves as a key access point into its broader diagnostics ecosystem, enabling timely virtual consultations and efficiently directing patients into its national network of diagnostic centres for follow-up testing and care. WELL plans to continue scaling the platform through additional recruitment of cardiologists and internal medicine specialists.Dr. Paul Kannampuzha, Chief Cardiology Officer at WELL, commented, "Wait times for specialist consultations remain a significant barrier to timely cardiac care in Canada. CardiologyNow was built to close that gap, and the momentum we are seeing in Q1 reflects the strength of this model. By combining rapid-access virtual consultations with a growing roster of cardiologists and seamless integration into our national diagnostic network, we are able to get patients in front of the right specialist quickly and move them into testing and treatment without delay."Footnotes:(1) Patient visits are defined by any interaction a patient has with a WELL practitioner through all sources and channels, including in-person, virtual, diagnostic testing consultations, and asynchronous physician consultations. Patient visit metrics are preliminary and subject to change from the Company's final Q1-2026 reported metrics.(2) Preliminary financial results are subject to change and may differ materially from the Company's final reported Q1-2026 financial results. Adjusted EBITDA is a non-GAAP measure. EBITDA represents net income (loss) before interest, taxes, depreciation and amortization. The Company defines Adjusted EBITDA as EBITDA, adjusted for items not reflective of ongoing operating performance, including transaction, restructuring and integration costs, share-based payments, time-based earn-out expense, changes in fair value, foreign exchange gains/losses, and certain revenue recognition adjustments under IFRS 15. Adjusted EBITDA should not be considered an alternative to net income (loss) or cash flow from operating activities determined in accordance with IFRS.(3) Clinic Absorptions refers to clinics joining WELL's clinic network for nominal consideration, contributing to organic growth. WELL HEALTH TECHNOLOGIES CORP.Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and DirectorAbout WELL Health Technologies Corp.WELL Health Technologies Corp. (TSX: WELL) is Canada's largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 4 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services. WELL provides cybersecurity services through its CYBERWELL subsidiary. WELL is publicly traded on the TSX under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF." To learn more, please visit: www.well.company.Forward-Looking StatementsThis news release contains "Forward-Looking Information" within the meaning of applicable Canadian securities laws, including statements regarding preliminary Q1-2026 financial results and patient visits, the continued expansion of WELL's Affiliate Clinic network, the growth of CardiologyNow, scaling the platform through additional recruitment of cardiologists and internal medicine specialists and future expansion plans. Forward-Looking Information is based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties and contingencies outside of WELL's control. Such Forward-Looking Information is not a guarantee of future performance. WELL's comments expressed or implied by such Forward-Looking Information are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL's control, and undue reliance should not be placed on such information. Forward-Looking Information is qualified in its entirety by inherent risks and uncertainties, including: direct and indirect material adverse effects from adverse market conditions; risks inherent in the primary healthcare and technology sectors generally; regulatory and legislative changes; that market competition may affect the business, results and financial condition of WELL; and other risk factors identified in documents filed by WELL under its profile at www.sedarplus.ca, including its most recent Annual Information Form and its Management's Discussion and Analysis. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise.For further information:Pardeep Sangha
Vice President, Investor Relations

WELL Health and WELLSTAR to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor ConferenceApril 13, 2026 7:30 AM
Newsfile2026 Bloom Burton & Co. Healthcare Investor Conference on April 21-22, 2026, in Toronto, ONVancouver, British Columbia--(Newsfile Corp. - April 13, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, and its majority-owned subsidiary WELLSTAR Technologies Corp. ("WELLSTAR"), Canada's leading provider of connected technology solutions for healthcare providers, are pleased to announce their participation as presenting companies at the 2026 Bloom Burton & Co. Healthcare Investor Conference on April 21-22, 2026 in Toronto, Ontario at the Metro Toronto Convention Centre. Representatives from WELL and WELLSTAR will deliver corporate presentations and participate in one-on-one meetings with investors during the conference.WELL PresentationPresentation Time: Wednesday, April 22, 2026 at 9:30 - 10:00 AM (ET) in Room 104 C/D
Presenter: Hamed Shahbazi, CEO and Chairman of WELL HealthWELLSTAR PresentationPresentation: Wednesday, April 22, 2026 at 10:30 - 11:00 AM (ET) in Room 104 C/D
Presenter: Amir Javidan, CEO of WELLSTARThe Bloom Burton & Co. Healthcare Investor Conference is Canada's premier healthcare investment event, bringing together leading publicly traded and private healthcare companies with institutional investors from across North America and internationally. Please contact your Bloom Burton representative for further information and to book a 1on1 meeting. WELL HEALTH TECHNOLOGIES CORP.Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director About WELL Health Technologies Corp. WELL is building the infrastructure for a healthier Canada. Through its comprehensive healthcare and digital platforms, WELL operates the largest owned and operated outpatient healthcare ecosystem in Canada with more than 250 clinics, and its technology solutions enable more than 43,000 healthcare providers across Canada and the US. WELL's subsidiaries include WELLSTAR, a pure-play healthcare SaaS platform, HEALWELL AI, a global healthcare AI company, and CyberWELL, a healthcare cybersecurity business unit. WELL is publicly traded on the Toronto Stock Exchange under the symbol 'WELL' and on the OTC Exchange under the symbol 'WHTCF'. To learn more about WELL, please visit: www.well.company. About WELLSTARWELLSTAR is a leading healthcare technology company dedicated to reshaping healthcare through digital enablement. We provide a comprehensive, holistic solution for healthcare providers across Canada, with over 40% of practitioners currently using our products and services. Our solutions serve primary care physicians, specialists, health systems, and public sector organizations through a comprehensive suite including billing and practice management systems, electronic medical records (EMRs), digital health applications, and digital health network solutions. As a majority-owned subsidiary of WELL Health, WELLSTAR continues to drive innovation and transformation in the Canadian healthcare landscape, reducing administrative burden and empowering providers to deliver better patient outcomes through advanced technology solutions. Learn more at www.wellstar.health. ? For further information:Pardeep Sangha
Vice President, Investor Relations

WLYYF changed to WHTCF:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

Alpha Status just covered well health

Well, well, well !....Let's SEE here now....





hmmmmmm, okay.......Good eye toastturtle

$WLYYF: HUGE POSSIBILITY of that happening


THis is no joke business.


THey are doing wayyyyyyyyyy better than their competitor which owns more market share right now



This will blow everyone away.


I saw the first day when that big investment from the Japanese investor came thru.


Follow the WHALES



GO $WLYYF

If you imply that nothing fundamental has changed and the company is progressing as expected I can see merit in your prediction.

I take it there is still the possibility of a buyout/merger?

$WLYYF: The path is clear here though........



You will see $25/sh in the not to distant future.


Take that to the bank !!!!!!



GO $WLYYF

Seems like we are in a prolonged time span of consolidation.

$WLYYF: Now 6.35............. still flying under the RADAR


Don't be shocked when this hits $40



Some massive things are going on here.



Especially when healthcare really starts rolling



GO $WLYYF

WOW, this company is on a roll. Do we know why the share price keep rising, is it based on anticipated good results of do we anticipate a takeover by a bigger fish?

I agree, I had a plan in place to buy a reasonable amount but already had to cut the number of shares I had in mind in half...lol

Amazing how this stock perform and I get the impression the CEO is not sitting around idle..

I hope it doesn’t get bought out! That seems like the only thing that can stop this run.

I must admit you got this one right!

I still think this one has a long way to go and I am not excluding more acquisition(s) and/or a buyout/takeover.

What is your take on the future?

$WLYYF: Been here since $1.31


Whatta sweet payoff............. told you Li Ka Shing was involved



Thats how you make that EZ Money !!!!!!!!!!!!



GO $WLYYF

$WLYYF: Mega $18.5Billion Merger today in Health SPACE


TelaDOC & LIVONGO !!!!!!!!!


What space is WEll HEALTH in ?


This is a future buyout target... MARK MY WORDS !!!!!!!!!!



Now at $3.22

Adding another 10k around this price level



GO $WLYYF





Teladoc Health Inc. (TDOC) and Livongo Health Inc. (LVGO) said Wednesday they have agreed to merge in a deal valued at $18.5 billion to create a company that can serve a spectrum of health needs, using virtual care. Under the terms of the deal, Livongo shareholders will receive 0.592x shares of Teladoc plus $11.33 in cash per share owned. Teladoc shareholders will own abut 58% of the combined entity, while Livongo shareholders will own the remaining 42%. The combination "creates a global leader in consumer centered virtual care," the companies said in a joint statement. The new entity is expected to have pro forma revenue of about $1.3 billion for 2020, equal to pro forma growth of 85%. "Livongo is a world-class innovator we deeply admire and has demonstrated success improving the lives of people living with chronic conditions," Teladoc Chief Executive Jason Gorevic said in a statement. Together, we will further transform the healthcare experience from preventive care to the most complex cases, bringing 'whole person' health to consumers and greater value to our clients and shareholders as a result." The deal is expected to close in the fourth quarter. The combined company is expected to generate revenue synergies of $100 million by the end of the second year after the deal closes and to achieve $500 million on a run rate basis by 2025. Gorevic will be CEO of the combined company, and the board will comprise eight members of the Teladoc board and five members of the Livongo board. Teladoc shares fell 2.3% premarket, while Livongo was up 6.9%. -Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com (END) Dow Jones Newswires 08-05-20 0741ET Copyright (c) 2020 Dow Jones & Company, Inc.

$WLYYF: Hit $5.40 yesterday



This thing is about to have a meteoric run into into 2021 now



GO $WLYYF

$WLYYF: Huge News today.... Cycura Services CyberSecurity

WELL Health Completes Acquisition of Cycura's Services Division and Forms New Cybersecurity Business Unit
8:00 AM ET 8/4/20 | Dow Jones


-- Cycura is a leader in providing top-tier cyber security services, whose

key principals have extensive experience in protecting patient health

data in the provincial Ministry of Health and acute care hospital

settings.

-- The acquisition is intended to elevate WELL's overall cybersecurity and

risk management program and provide WELL with another compelling

opportunity to build shareholder value through accretive and disciplined

capital allocation in the cybersecurity space.

-- In the past 12 months, Cycura's Services Division has generated revenues

of more than $1.7M with better than double digit EBITDA(1) profitability.

VANCOUVER, BC, Aug. 4, 2020 /CNW/ - WELL Health Technologies Corp. (TSX: WELL) (the "Company or "WELL"), is pleased to announce that it has completed its previously announced acquisition of the Services Division of Cycura Inc.(2) , a private Ontario corporation. The purchase price was approximately $2.55M, paid entirely with cash on hand, and subject to certain holdbacks, adjustments, and time-based payments. In the past 12 months, Cycura Inc.'s Services Division generated revenues exceeding $1.7M with EBITDA margins of over 10%. In addition, WELL announces it is retaining the Cycura brand name and the formation of a new business unit called Cycura Data Protection Corp. ("Cycura"). This new business unit will be led by Iain Paterson, who was previously the Managing Director of Cycura Inc. and will be the CEO of Cycura going forward. Iain will be supported closely by Melinda Coultar who was the Director of Consulting at Cycura Inc., and will now see an elevated role serving as Vice President of Services.

"We are very excited to welcome the talented and experienced team from Cycura led by Iain and Melinda and look forward to their leadership of the new Cybersecurity business unit at WELL," said Hamed Shahbazi, Chairman and CEO of WELL. "We believe this business unit will be a key leader and consolidator in the Canadian cybersecurity space with the overarching goal of helping keep private data including highly sensitive health data safe and secure"

Cycura provides industry leading cybersecurity services including penetration and vulnerability testing, security focused code reviews, incident response services, cybersecurity training, cybersecurity M&A advisory and technical due diligence services, and more. Cycura will operate as a wholly owned subsidiary of WELL, providing cyber security protection and patient data privacy solutions across all of the Company's business units including WELL Health Clinic Network, WELL EMR Group and WELL Digital Health Apps. In addition, Cycura will continue to serve its existing customers across a broad array of industries, including healthcare clients focusing on mental health, telemedicine, health insurance and benefits.

"We are excited to join WELL who shares our belief in the importance of improving cybersecurity resilience in the healthcare and health tech sector," said Iain Paterson, CEO of Cycura. "While Cycura will continue to serve our valued customers across a broad array of industries, we believe this is a tremendous opportunity for us to increase our market share in healthcare, while operating as a standalone business within WELL."

Mr. Paterson is a highly skilled information security leader and practitioner with more than 15 years of experience in enterprise wide information technology. Previously, Mr. Paterson was the Information Security Officer for Trillium Health Partners, one of the largest hospitals in Canada and worked under the office of the CISO at eHealth Ontario, which houses the healthcare records of 13M Ontario citizens and acts as the main data share for the majority of Ontario's hospitals. Iain holds an MBA with a focus in Leadership and Innovation, and has industry CISSP, CISM and SABSA certifications.

All key employees of Cycura are being retained under Mr. Paterson and Ms. Coultar's leadership whose focus and energy will ensure that WELL not only continues to provide the high quality service that clients have come to expect from the Cycura brand, but also expand product and service offerings so that Cycura can tackle a greater number of challenges and be a more valuable vendor to its client base.

Cycura was initially founded and supported by a diverse and successful group of investors and operators represented by Mr. Eitan Popper. WELL extends its appreciation to this group for their hard work in consummating the transaction.

"This is a beneficial transaction for both WELL and Cycura Inc. The importance of cybersecurity for practically any industry has become an indisputable reality. I believe that WELL will be able to leverage the capabilities of the Services Division of Cycura Inc., while at the same time enabling and supporting the Division's growth", stated Eitan Popper, Chairman of Cycura Inc.

1. EBITDA is a Non-GAAP measure. Earnings before interest, tax,

depreciation and amortization ("EBITDA") should not be construed as an

alternative to net income/loss determined in accordance with IFRS. EBITDA

does not have any standardized meanings under IFRS and therefore may not

be comparable to similar measures presented by other issuers. The

Company believes that EBITDA is a meaningful financial metric as it

measures cash generated from operations.

2. As a condition of the transaction, Cycura Inc. will change its name while

WELL will retain the Cycura name and brand and henceforth operate the

Cycura Services Division as Cycura Data Protection Corp.

WELL HEALTH TECHNOLOGIES CORP.

Per: "Hamed Shahbazi"

Hamed Shahbazi

Chief Executive Officer, Chairman and Director

About WELL Health Technologies Corp.

WELL is an omni-channel digital health company whose overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest technology and trends in digital health. As such, WELL owns and operates 20 primary healthcare medical clinics, is Canada's third largest Electronic Medical Records (EMR) supplier serving over 1,900 medical clinics, operates a leading national telehealth service and is a provider of digital health technology solutions. WELL is an acquisitive company that has completed twelve acquisitions and three equity investments. The Company is publicly traded on the Toronto Stock Exchange under the symbol "WELL". WELL was recognized as a TSX Venture 50 Company three years in a row in 2018, 2019 and 2020. To access the Company's telehealth service, visit: virtualclinics.ca and for corporate information, visit: www.WELL.company.

Notice Regarding Forward Looking Statements:

Certain statements in this news release related to the Company are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as "may", "should", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Forward-looking statements in this news release include: statements regarding the closing of the Transaction, post-closing objectives of WELL for the Cycura brand, the expectation that the Transaction will be immediately accretive to WELL, and the anticipated margins thereof, the statement that the business unit will be a key leader and consolidator and the intention to retain all key employees of Cycura. There are numerous risks and uncertainties that could cause actual results and WELL's plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; and (ii) risks inherent in the cyber security industry in general and other factors beyond the control of the Company; (iii) risks related to the inability to close the Agreement for any reason; (iv) difficulties associated with the integration of the business; and (v) risks outlined in WELL's publicly filed periodic documents available on SEDAR. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.

Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE WELL Health Technologies Corp.

View original content to download multimedia: www.newswire.ca/en/releases/archive/August2020/04/c0176.html

/CONTACT:

Pardeep S. Sangha, Vice President Corporate Strategy and Investor Relations, investor@well.company, 604-572-6392

/Web site: well.company

Copyright CNW Group 2020

> Dow Jones Newswires

August 04, 2020 08:00 ET (12:00 GMT)

$WLYYF: Told you we're going to $20


And we are.

Lots of people still don't understand what they do.


I do............ and have, for quite some time now.


Sitting on only 25k shares.


No biggie.



GO $WLYYF

5+

$WLYYF: Going to $20 very shortly


Looking JUSTTttttttttttt beautiful.


Excellent here at 2.50 now



GO $WLYYF

$WLYYF: Going to $20 very shortly


Looking JUSTTttttttttttt beautiful.


Excellent here at 2.50 now



GO $WLYYF

$WLYYF: Almost 200k traded............ getting prepped for BUYOUT


https://www.cantechletter.com/2020/04/well-health-is-a-potential-take-out-target-stifel-gmp-says/




The growth here is undeniable.


Its going realllllllllllllllllllllllllly well !



GO $WLYYF




*****************************************************************




WELL Health Closes Strategic Investment in Insig Corporation and Rapidly Expands VirtualClinic Telehealth Program
7:30 AM ET 4/8/20 | Dow Jones


-- WELL Health has closed its previously announced share exchange

acquisition of approximately $3.94M in Insig shares and WELL's CEO Hamed

Shahbazi has joined Insig's board of directors.

-- This investment brings WELL's total investment in Insig to approximately

$5.94M, including the previously announced $2M secured, convertible

promissory note. Assuming the note will be fully converted, WELL becomes

the largest shareholder of Insig.

-- In addition, in accordance with its strategic alliance agreement with

Insig, WELL continues to rapidly grow and expand "VirtualClinic+", WELL's

own telehealth program to healthcare providers and patients across

Canada.

VANCOUVER, April 8, 2020 /CNW/ - WELL Health Technologies Corp. (TSX: WELL) ("WELL" or the "Company") announces, further to its news release dated March 26, 2020, that it has completed all components of its strategic investment in Insig Corporation ("Insig"), a market leader in the telehealth space in Canada.

WELL, Insig and certain shareholders of Insig entered into a share exchange agreement whereby the Company acquired a substantial minority equity position in Insig, comprised of approximately 2,625 Class A common shares of Insig ("Insig Shares"), in exchange for an aggregate consideration of 2,625,204 common shares in the capital of WELL at a deemed price of $1.50 per share, representing deemed consideration of approximately $3.94 million.

Including WELL's previously announced investment in Insig of a $2M secured, convertible promissory note (the "Convertible Note"), the Company's aggregate total investment in Insig is approximately $5.94M. WELL becomes the largest shareholder of Insig assuming full conversion of the Convertible Note.

Furthermore, WELL entered into a strategic alliance agreement with Insig which allowed WELL to commercialize and launch the Insig platform on a private label basis under the brand "VirtualClinic+". WELL's investment and partnership with Insig positions the Company as a leading provider of telehealth services in Canada. WELL's CEO Hamed Shahbazi has also joined Insig's board of directors and will help support Insig's efforts to grow and meet the rapidly expanding need for telehealth services amongst Canadian doctors and patients.

"WELL has seen tremendous interest and activity in its VirtualClinic+ telehealth service, which now includes hundreds of healthcare practitioners delivering thousands of consultations per week," said Hamed Shahbazi, Chairman and & CEO of WELL. "We are thrilled to be partnering with the Insig team to deliver highly accessible quality healthcare for Canadians at this critical time. Also, I am personally looking forward to serving on the Insig board and furthering the success of what we believe to be, the most exciting telehealth platform in the country."

"We are excited to have WELL as both an investor and a strategic partner, " said Matthew Mazzuca, CEO of Insig. "WELL's leadership and network in the healthcare industry is a great fit with our technology platform. Working together we can deliver a telehealth solution that meets the needs of Canadian doctors while improving patient access to healthcare."

To access WELL's VirtualClinic+ telehealth service, visit virtualclinics.ca.

WELL HEALTH TECHNOLOGIES CORP.

Per: "Hamed Shahbazi"

Hamed Shahbazi

Chief Executive Officer, Chairman and Director

About WELL Health Technologies Corp.

WELL is a unique company that operates Primary Healthcare Facilities, is the third largest digital Electronic Medical Records (EMR) supplier in Canada and is a provider of telehealth services. WELL owns and operates 21 healthcare clinics, provides digital EMR software and services to 1,446 clinics across Canada and is a majority owner of SleepWorks Medical. WELL's overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health. WELL is an acquisitive company that has completed nine acquisitions and two equity investments. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL-T". WELL was recognized as a TSX Venture 50 Company three years in a row in 2018, 2019 and 2020.

About Insig Corporation

Insig is a private Canadian company engaged in developing telemedicine platforms, and clinical automation software. Insig has grown to serve hundreds of physicians and medical practitioners across the country, with over 100,000 patients having used the platform. Insig's goal is to remove the administrative burden in medical practice so doctors can focus on what they do best, practice medicine.

Notice Regarding Forward Looking Statements:

Certain statements in this news release related to the Company are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as "may", "should", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding: the assumption that the Convertible Note will be fully converted, and WELL will maintain its position as Insig's largest shareholder; the ability of the strategic alliance and Hamed Shahbazi's appointment to Insig's board of directors to support Insig's efforts to grow and meet the rapidly expanding need for telehealth services amongst Canadian doctors and patients; the ability of the Company and Insig to work together to continue to rapidly ramp up the availability of telehealth services to all Canadians to meet the increasing demand for healthcare services as a result of COVID-19; and the assumption that the strategic partnership between WELL and Insig can deliver a telehealth solution that meets the needs of Canadian doctors while improving patient access to healthcare. There are numerous risks and uncertainties that could cause actual results and WELL's plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; and (ii) risks inherent in the primary healthcare sector in general and other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.

Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE WELL Health Technologies Corp.

View original content to download multimedia: www.newswire.ca/en/releases/archive/April2020/08/c8022.html

/CONTACT:

Pardeep S. Sangha, VP Corporate Strategy and Investor Relations, WELL Health Technologies Corp., pardeep.sangha@well.company, www.WELL.company, 604-628-7266; David Del Balso, President, Insig Corporation, david@insighealth.com, www.insighealth.com

/Web site: well.company

Copyright CNW Group 2020

> Dow Jones Newswires

April 08, 2020 07:30 ET (11:30 GMT)

$WLYYF: Verrrrrrrryyyyyy impressive................ Over 80k traded


Up to $1.70


Can you see a massive run coming here ?


This is some serious loading now on a low floater.



Watch this fly on some fortunate stops up to $100



GO WLYYF

$WLYYF: Couldn't help it... got more shares



Sooooooooooooooooo cheap still at 1.63



Make sure you Send me a GIFT when we're at $50



GO $WLYYF

$WLYYF: I never have to POST HERE


One day........ out of NOWHERE


This will be at $100/sh



I know.



GO $WLYYF

$WLYYF: I love this one.


There is a great flag on this right now.


A move to $7 is sooooooooooo doable.


Right now at $1.18



Could go like $SAVA has been going recently.


GO $WLYYF

This company seems to be firing on all cylinders. I’m surprised that it is on so few people’s radar!

$WLYYF: More M&A and Growth in the Cards


"SIGNIFICANT UPSIDE"





https://www.cantechletter.com/2019/09/well-health-is-set-for-more-ma-growth-says-pi-financial/



GO $WLYYF


********************************************************************



Well Health is set for more M&A growth, says PI Financial
SEPTEMBER 17, 2019 BY JAYSON MACLEAN

WELL Health Technologies GMPIt’s a matter of when not if Well Health Technologies (Well Health Stock Quote, Chart, News TSXV:WELL) will be making more moves on the M&A front, says PI Financial analyst David Kwan.

In a corporate update on Monday Kwan reiterated his “Buy” rating and $1.80 per share target price for WELL. Kwan says he marketed Chairman and CEO Hamed Shahbazi last week, detailing the company’s disciplined focus on capital allocation.

“The M&A pipeline remains top of mind for investors,” says Kwan. “On that front, WELL has close to a dozen targets at various stages of the LOI process (split ~50/50 between chains of clinics and EMR/software companies) while it has a modestly larger number of additional targets where they are at an earlier stage of the M&A process.”

“WELL is focused on expanding its clinic footprint in Ontario but is also looking at growing its presence in B.C., while on the digital services front, WELL is looking to further consolidate the OSCAR market while adding complementary technologies like telemedicine,” said Kwan, who noted that to date, every LOI that WELL has signed has resulted in an acquisition, suggesting that we should expect more acquisitions in the quarters and years to come.

Kwan evaluates the marketing event as slightly positive for the stock and adds that WELL is now evaluating the possibility of up-listing to the TSX, which would open up the company to a larger set of potential investors and potentially bolster the stock’s valuation.

Well Health’s share price took off in early July on press coverage of the stock, taking it from the $0.90 range to where it currently resides in the $1.60 range. Year-to-date, WELL is up 269 per cent.

Kwan’s $1.80 target is based on a 4.5x multiple of his fiscal 2020 revenue estimate for WELL’s digital services business and a 3.5x multiple of his fiscal 2020 revenue estimate for WELL’s clinic business. The target represents a projected 12-month return of 9.1 per cent at the time of publication.

Kwan says WELL has the war chest available to keep the acquisitions coming.

WELL Health stock could have “significant” upside…
“With a cashed up balance sheet and the Company expected to turn cash flow positive soon, we note that WELL has plenty of additional capital to deploy for acquisitions that could provide (significant) upside to our forecasts,” he writes.

Going forward, the analyst thinks WELL will generate fiscal 2019 revenue and adjusted EBITDA of $31.4 million and negative $1.6 million, respectively, and fiscal 2020 revenue and EBITDA of $56.1 million and $2.7 million, respectively.

Last month, Vancouver-based Well Health released its second quarter 2019 financials, featuring revenue of $7.4 million, a 258-per-cent increase year-over-year and an adjusted EBITDA loss of $287,000.

Over the quarter, WELL completed its acquisition of OCSARprn – Treatment Solutions, while subsequent to the quarter, the company completed the acquisition of Kela Atlantic dba KAI Innovations.

“Q2 was an excellent quarter for us which demonstrated continued strong clinical revenue growth and increasing gross margin from our SaaS based EMR service,” said Hamed Shahbazi, Chairman and CEO of WELL. “In addition, the recently completed acquisition of KAI Innovations has been a very strong fit with our prior EMR related acquisitions and has spurred new growth and expanded capabilities in our EMR business.”

Disclaimer: Nick Waddell and Jayson MacLean from Cantech Letter own shares of WELL Health and the company is an annual sponsor of this publication.

I cant believe people are not following this billionaire play...this will explode long term fr sure

$WLYYF: Li-Ka-Shing to continue investing in $WLYYF


Growth trajectory is inevitable.


Going to take out their competitors



GO $WLYYF

$WLYYF: 2019 Revenues going to be $44-50Million


HUGE !!!!!!




GO $WLYYF

$WLYYF: Kai Innovations bought Trimara in 2016



Question is...... who is Hamed & Team going to buy NEXT ?


https://www.canhealth.com/2016/04/06/kai-innovations-buys-oscar-specialist-trimara/



GO $WLYYF

$WLYYF: Power of OSCAR & Kai-Innovations Acquisition


kaiinnovations.com/oscar/





http://www.lionelbebbington.com/new-gallery

$WLYYF: Corporate VIDEO


https://vimeo.com/332106168







GO $WLYYF

$WLYYF: Full Spread in Financial Post


the WeWork of DOCTORS



https://business.financialpost.com/investing/li-ka-shings-canadian-bet-aims-to-halt-doctors-paper-trails



https://www.cantechletter.com/2019/06/theres-even-more-upside-in-store-for-well-health-says-beacon-securities/



GO $WLYYF

$WLYYF: Li-Ka-Shing owns 10Million Shares


The remainder owned by Shahbazi.


https://www.cantechletter.com/2019/06/li-ka-shing-invests-more-money-in-canadas-well-health-technologies/




GO $WLYYF

$WLYYF: Li-Ka-Shing HK Billionaire Investor in $WLYYF



In an effort to get rid of paper charts, billionaire Li Ka-Shing is investing in Well Health Technologies Corp, a Vancouver based start-up that is hoping to bring Canada's fragmented primary care system into the digital era: https://t.co/rskymFjJQn #digitalhealth pic.twitter.com/6rymvibXL3— IHPME (@ihpmeuoft) July 7, 2019


https://www.bnnbloomberg.ca/li-ka-shing-s-canadian-bet-aims-to-halt-doctors-paper-trails-1.1282605


Currently at $1.16



Going to $50 in short time.




GO $WLYYF

$WLYYF: Huge Acquisition... Kai Innovations for $10.5MIllion



Running now at $1.31



No Limit on the ASK..... Sky HIGH clear on the L2



GO $WLLYF



*****************************************************


Press Release: WELL Health Completes Acquisition of Kai Innovations, Canada's largest provider of OSCAR EMR Services
8:05 AM ET 7/2/19 | Dow Jones


WELL Health Completes Acquisition of Kai Innovations, Canada's largest provider of OSCAR EMR Services

Canada NewsWire

VANCOUVER, July 2, 2019

-- Acquisition of KAI has significantly expanded WELL's digital health

portfolio to now provide Electronic Medical Records ("EMR") SaaS1

services to approximately 852 medical clinics across Canada, supporting

more than 4000 registered doctors & practitioners and over 15 million

patients2

-- KAI's award winning founders, Arjun Kumar and Sara Bond have joined

WELL's technology management team and will help drive the digital health

portfolio of the company.

-- Acquisition of KAI is immediately financially accretive to WELL and is

expected to improve WELL's gross margin and operating margin

VANCOUVER, July 2, 2019 /CNW/ - WELL Health Technologies Corp. (TSX.V: WELL) (the "Company" or "WELL"), a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector, is pleased to announce the closing of its previously announced acquisition (the "Acquisition") of Kela Atlantic Inc. dba KAI Innovations ("KAI"). KAI provides SaaS (Software as a Service) based Electronic Medical Records ("EMR") services to approximately 562 clinics in Ontario, supporting approximately 2,100 registered doctors and practitioners.

"KAI is highly accretive to WELL on both a strategic and financial basis" said Hamed Shahbazi, Chairman and CEO of WELL, "With this acquisition, WELL is now the largest provider of OSCAR(3) EMR services in Canada supporting approximately 852 clinics, which to our understanding positions the Company as the third largest EMR services provider in Canada. We're very pleased to welcome the talented KAI team to the WELL family."

KAI, the recipient of Canadian Business Magazine's 2015 Startup of the Year, has the third largest EMR user base in Ontario and is the largest provider of OSCAR EMR services to healthcare clinics in Canada.

"We're very pleased to be joining the WELL team and helping drive the next generation of digital health innovation in Canada" said Arjun Kumar, co-Founder and CEO of KAI Innovations. "We're also looking forward to continuing to support the OSCAR community and ensuring that this community continues to grow and thrive as the industry changes with WELL's support".

The details of the Acquisition were previously announced in the Company's news release dated May 30, 2019. Pursuant to the share purchase agreement dated May 30(th) , 2019 and amended on June 28(th) , 2019, the aggregate purchase price for KAI was approximately $10,750,000, consisting of the following: (i) $6,000,000 paid in cash upon closing of the Acquisition; (ii) $2,000,000 paid in the capital of WELL shares at a price of approximately $0.705 per share; and (iii) cash payments of $2,750,000 to be paid in the first year after closing. In addition, WELL will pay a conditional earn-out based on overall operating performance of up to $7,000,000.

The consideration shares issued by WELL are subject to a restricted period of four months and one day. There were no finder's fees paid in connection with the Transaction.

1. SaaS is a acronym for "Software as a Service"

2. Patient count is based on total number of patient profiles and does not

exclude duplicate patient records, inactive or deceased patients.

3. OSCAR, an acronym for "Open Source Clinical Application Resource", is a

leading open source based EMR software that was developed by McMaster

University.

WELL HEALTH TECHNOLOGIES CORP.

Per: "Hamed Shahbazi"

Hamed Shahbazi

Chief Executive Officer, Chairman and Director

About WELL

WELL is a unique company that operates Primary Healthcare Facilities as well as a significant EMR or Electronic Medical Records business that provides SaaS EMR services to more than 4000 doctors across Canada. WELL's overarching objective is to empower doctors to provide the best and most advanced care possible leveraging the latest trends in digital health. In the last 12 months, WELL physicians served approximately 600,000 patient visits through its network of 19 medical clinics. WELL is publicly traded on the TSX Venture Exchange under the symbol WELL.V. WELL was recognized as a TSX Venture 50 Company in 2018 and 2019.

Forward-Looking Statements

This news release may contain "forward-looking statements" within the meaning of applicable Canadian securities laws, including, without limitation: the ability of WELL to provide and continue providing services to the anticipated number of clinics, practitioners and patients; and the belief that such acquisitions will position WELL as one of the leading EMR providers in Canada. Forward looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties, and contingencies. These statements generally can be identified by the use of forward-looking words such as "may", "should", "will", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause future results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. WELL's statements expressed or implied by these forward-looking statements are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL's control, and undue reliance should not be placed on such statements. Forward-looking statements are qualified in their entirety by the inherent risks and uncertainties surrounding the Transaction, including: that WELL's assumptions in making forward-looking statements may prove to be incorrect; adverse market conditions; risks inherent in the primary healthcare sector in general; that future results may vary from historical results; and that market competition may affect the outcome of the business, results and financial condition of WELL. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

SOURCE WELL Health Technologies Corp.

View original content: www.newswire.ca/en/releases/archive/July2019/02/c8503.html

/CONTACT:

Pardeep S. Sangha, VP Corporate Strategy and Investor Relations, investor@well.company, www.WELL.company, 604-628-7266

/Web site: www.well.company

Copyright CNW Group 2019

> Dow Jones Newswires

July 02, 2019 08:05 ET (12:05 GMT)